Should you Hold Precigen (PGEN)?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Precigen Inc. (PGEN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.85 | 58,823 | Officer | 743,097 | 2024-08-09 | Filing | |
| $0.85 | 23,529,411 | 64,547,214 | 2024-08-09 | Filing | ||
| $1.41 | 96,686 | 1,096,686 | 2023-12-28 | Filing | ||
| $1.41 | 25,000 | Director | 356,836 | 2023-09-22 | Filing | |
| $1.51 | 119,411 | 31,837,786 | 2023-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.41 | 96,686 | Director | 238,275 | 2023-12-28 | Filing | |
| $1.53 | 76,969 | Officer, Director | 1,560,004 | 2023-08-25 | Filing | |
| $1.64 | 10,947 | Officer | 428,916 | 2023-08-24 | Filing | |
| $1.64 | 5,388 | Officer | 133,474 | 2023-08-24 | Filing | |
| $1.64 | 8,891 | Officer | 458,903 | 2023-08-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
Precigen, Inc. (NASDAQ:PGEN) Q2 2024 Earnings Call Transcript
Operator: Good evening and welcome to the Precigen’s Second Quarter and First Half 2024 Financial Results Call. At this time, all lines are in a listen-only mode.
Analysts on Wall Street Lower Ratings for These 10 Stocks
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript
Precigen, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $-0.08.
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More
George Soros has been branded as a bogeyman by the right wing for backing liberal causes around the globe.
Precigen, Inc. (NASDAQ:PGEN) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Precigen Second Quarter and First Half 2023 Financial Results and Business Update Call. Please note this event is being recorded.
Precigen, Inc. (NASDAQ:PGEN) Q1 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Precigen First Quarter 2023 Financial Results and Business Update Call. All participants will be in the listen-only mode.
5 High Growth Penny Stocks that are Profitable
Ring Energy, Inc. (NYSE:REI) is an oil and gas producer with close to 80 million barrels of proven reserves.
5 High Growth Pharma Stocks that are Profitable
Halozyme Therapeutics, Inc. (NASDAQ:HALO)'s third quarter of 2022 results saw the firm bring in $209 million in revenue, which marked a strong 80% annual growth.
Hedge Fund and Insider Trading News: Whitney Tilson, Crispin Odey, Steve Cohen, Cevian Capital, Bridgewater Associates, Verde Asset Management, Precigen, Inc. (PGEN), Phillips 66 (PSX), and More
Ken Griffin's Citadel extended its winning streak with gains in January, weeks after ending 2022 with a $16 billion gain, the biggest profit ever earned by a hedge fund.